Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Point Biomedical Corp.

www.pointbio.com

Latest From Point Biomedical Corp.

What Entrepreneurs Want, Get, and Don't Get from VCs

What makes a health care VC stand out in the minds of entrepreneurs? According to a first-of-its-kind survey by Windhover, PricewaterhouseCoopers, Wilson Sonsini, and Applied Information Networks, the answer is value-added services. Entrepreneurs prize VCs who assist them, pre-financing, with constructive feedback and sharing of due diligence results. VCs do pretty well here. But they do less well on the more important post-financing criteria: helping their portfolio companies secure additional financing and recruit customers, partners, and employees.
BioPharmaceutical Medical Device

ImaRx Therapeutics Inc.

ImaRx Therapeutics Inc. aims to use a diagnostic contrast agent as a vehicle for drug and gene delivery. The company will encapsulate a therapeutic payload in a synthetic microbubble, inject it into the body, then apply ultrasound across the skin to rupture the microbubble at the targeted site. Shockwaves from the rupture are thought to permeate capillary walls and drive the drug or gene instantaneously into the targeted tissue.
BioPharmaceutical

Point Biomedical: Planning for Uncertainty

Point Biomedical is developing a third-generation ultrasound contrast agent before second-generation agents have been successfully adopted. But as a small company, it must make choices about what it can realistically handle and what it can't--thus it is purusing a second business in acoustic drug delivery, but passing on urological and surgical applications of its biomaterials technology.
BioPharmaceutical Medical Device

Biomaterials: Mechanical Engineering Meets Biology

Start-ups developing man-made surrogates for living processes hope to achieve the alchemy of turning base materials into human tissue.
Medical Device Strategy
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Ultrasound
  • Pharmaceuticals
    • Drug Delivery
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Point Biomedical Corp.
  • Senior Management
  • Thomas L Feldman, Pres. & CEO
    Lee Rauch, CBO
    Padmanabh Bhatt, VP, R&D
  • Contact Info
  • Point Biomedical Corp.
    Phone: (650) 596-1400
    887L Industrial Rd.
    San Carlos, CA 94070
    USA
UsernamePublicRestriction

Register